Most people who end up here have already tried the conventional route. The antidepressants. The adjustments. The waiting. And still, something remains stuck. Intranasal ketamine exists for exactly that situation, and the science behind why it works is more compelling than most people realize before their first consultation.
Compounded intranasal ketamine is racemic ketamine prepared as a nasal spray by a licensed compounding pharmacy under a clinician’s prescription. A clinician administers it using a nasal atomizer in a supervised clinical environment, where the nasal mucosa absorbs the medication directly into the bloodstream. This is an off-label treatment. Ketamine carries FDA approval as an anesthetic, and a substantial body of peer-reviewed research supports its psychiatric applications, but the FDA has not approved those applications as indications.
The mechanism is the same one that makes IV ketamine so clinically significant. Ketamine blocks NMDA receptors within the glutamate system, triggering rapid BDNF release and a measurable surge in neuroplasticity. New synaptic connections begin forming within hours of administration. That neuroplastic window is the biological opportunity that separates ketamine from every antidepressant developed around serotonin, and intranasal delivery makes it accessible through a route that requires no intravenous access and carries a gentler onset profile than infusion.
For people who have not found adequate relief through conventional treatment, intranasal ketamine represents a distinct, clinician-managed entry point into neuroplastic care.
Before we write any prescription, your clinician conducts a thorough review of your mental health history, previous treatments, current symptoms, and medical background. Your clinician carefully screens for contraindications, answers your questions in full, and designs a personalized protocol around your specific situation.
You come in for your scheduled session, settle into a private clinical environment, and self-administer the intranasal ketamine using an atomizer under your clinician’s direct supervision. Your care team monitors vital signs continuously throughout. Mild dissociation or altered perception during the session is expected, temporary, and resolves fully within the observation window.
Following each session, you rest in our supervised clinical environment for a minimum of 2 hours while your care team monitors your response. Driving is not permitted after treatment, so arrange transportation in advance. Once your initial series is complete, your provider assesses your progress, builds a maintenance plan, and coordinates your ongoing care across all relevant services.
The evidence supporting compounded intranasal racemic ketamine is specific, reproducible, and drawn from people whose depression had already failed conventional treatment.
Research published in the International Journal of Molecular Sciences confirms that BDNF expression is significantly reduced in the prefrontal cortex and hippocampus in people living with depression, and this impairment of neuroplasticity is central to the disorder’s pathophysiology (Pardossi et al., 2024). Ketamine’s NMDA blockade rapidly increases BDNF and promotes new synaptic connections in the regions most critical to mood regulation, with benefits beginning within hours of a single administration rather than the weeks required by conventional antidepressants.
A Yale study published in Nature Communications confirmed that ketamine disinhibits dendrites and suppresses inhibitory interneurons in the medial prefrontal cortex, restoring synaptic activity in the dendritic spines of pyramidal neurons (Kwan, 2020). Intranasal delivery achieves this same neuroplastic effect through a non-invasive, clinician-supervised route.
Research published in the International Journal of Neuropsychopharmacology further describes how ketamine modulates brain systems supporting reward processing, interoception, and self-related cognition, providing a neurocognitive framework that helps explain why its antidepressant effects arrive so rapidly and feel so distinct from conventional treatment (Dai et al., 2025).
Ketamine does something no serotonin-targeting antidepressant does. It blocks NMDA receptors in the glutamate system, triggering a cascade of neuroplastic change, including increased BDNF release, accelerated synaptic growth, and restored neural connectivity. These changes begin within hours. Conventional antidepressants build effect over weeks. Many people with treatment-resistant depression never respond to them at all.
Administered through an atomizer, the nasal mucosa absorbs the medication into the bloodstream. The onset is gentler than IV administration. Peak effects are milder, which most people find more comfortable. The underlying glutamatergic mechanism is identical.
During administration, people commonly notice mild dissociation, softened emotional weight, and altered time perception. These effects resolve fully within the observation window. They are not unwanted side effects to be managed. They are the neurological opening that makes ketamine therapeutically meaningful. When combined with psychotherapy or other treatment modalities, each component reinforces the others.
Physical sensations you may notice include a sense of relaxation or mild floating, slight tingling, temporary changes in blood pressure or heart rate (your care team monitors these continuously), and occasional heaviness or numbness in the limbs.
Perceptual and mental effects may include mild dissociation or a dreamlike quality, an altered sense of time or space, softened emotional state, visual shifts, and emerging feelings or insights. Temporary memory effects during the administration window are normal.
Everything that happens during a session is temporary and resolves during the supervised observation period. A qualified clinician is present throughout.
During administration, you may experience nausea (brief and manageable), dizziness, a temporary increase in blood pressure, and perceptual changes that resolve within the observation window.
Following treatment, same-day fatigue, a mild headache, and occasionally vivid dreams that night are the most commonly reported effects.
Rare effects include brief anxiety during administration and momentary confusion when returning to baseline. Bladder irritation is associated only with chronic, high-dose, unsupervised use and does not occur in supervised clinical protocols.
Intranasal ketamine is not appropriate for everyone. People with uncontrolled cardiovascular disease, a history of psychosis or schizophrenia, active substance use disorder, pregnancy or breastfeeding, certain liver conditions, or uncontrolled thyroid disease are typically not candidates. Your provider screens thoroughly for all contraindications before writing any prescription.
A licensed clinician writes every prescription. A clinician administers every session under direct medical supervision. That structure separates therapeutic use from unsupervised use and allows your care team to monitor your response, adjust your protocol, and manage any side effects as they emerge.
Intranasal ketamine does not exist in isolation here. If you also receive TMS therapy, IV ketamine, psychotherapy, or medication management, your provider coordinates every modality so that each piece of your treatment plan works toward the same clinical outcome at the same tim
Intranasal ketamine is an off-label treatment, and we say so clearly from the first conversation. You will understand what the evidence supports, where its limits are, and exactly what you agree to before we write any prescription. Informed consent is not a checkbox here. It is part of the clinical process.
For people who want access to ketamine's neuroplastic mechanism but for whom IV administration is not the right fit, intranasal delivery provides a clinically supported, non-invasive alternative with its own evidence base and its own specific clinical applications.
A licensed pharmacy compounds the medication to your specific prescription rather than manufacturing it in standardized commercial doses. This means your provider can adjust dosing to reflect your actual clinical response, your history, and your treatment goals. That flexibility is a practical advantage of the compounded format.
Insurance Coverage: Most insurance plans do not cover intranasal ketamine because it is an off-label treatment. Most people pay out-of-pocket for this service. We confirm coverage details with you before treatment begins so there are no surprises.
Self-Pay Options: For people paying out-of-pocket, we offer transparent session and prescription pricing, flexible payment plans, and FSA/HSA acceptance.
The Value Perspective: For someone who has cycled through antidepressants without adequate relief, intranasal ketamine provides access to a neuroplastic mechanism that conventional medications simply do not reach, through a non-invasive format that fits more clinical situations and personal preferences than IV administration alone. We discuss all costs and payment options openly during your initial consultation.
Both deliver racemic ketamine and work through the same NMDA receptor mechanism. The differences are in route of administration, onset profile, and bioavailability. IV ketamine is delivered directly into the bloodstream, producing a faster and more intense onset. Intranasal ketamine is absorbed through the nasal mucosa, producing a gentler onset with lower peak intensity. IV ketamine has higher bioavailability, which is reflected in dosing differences between the two formats. For patients who want access to ketamine’s neuroplastic mechanism without IV administration, intranasal delivery is a clinically supported alternative.
No. Ketamine is FDA-approved as an anesthetic. Its use for depression, PTSD, anxiety, OCD, and related conditions is off-label. Compounded intranasal racemic ketamine is not FDA-approved for any psychiatric indication. That said, off-label prescribing is a standard and legal practice in medicine, and the evidence supporting ketamine’s antidepressant mechanism is substantial across decades of peer-reviewed research.
Many patients notice the neuroplastic effects of ketamine within hours of administration, including mood shifts, reduction in depressive heaviness, and changes in thought patterns. The speed of clinical response is one of ketamine’s most clinically significant features, differentiating it sharply from conventional antidepressants that require weeks to build effect. Individual responses vary, and your provider will monitor your progress throughout your treatment series rather than in a single session.
You arrive at our West Palm Beach clinic and are settled into a private, supervised treatment room. The intranasal ketamine is self-administered under your clinician’s direct supervision using a nasal atomizer. You then rest comfortably in the supervised environment while your vital signs are monitored. The effects typically include mild dissociation, altered time perception, and a sense of emotional softening that resolves within the observation window. You will be monitored for a minimum of two hours following administration before you are cleared to leave with your arranged transportation.
The number of sessions varies based on your diagnosis, symptom history, and clinical response. Most patients complete an initial induction series followed by a reassessment. Some achieve meaningful improvement after the induction phase. Others benefit from ongoing maintenance sessions to sustain and build on their gains. Your provider will build a plan based on how you are actually responding rather than applying a fixed protocol.
Yes. Intranasal ketamine is coordinated with your full treatment plan at HOPE Therapeutics. If you are also receiving TMS, psychotherapy, medication management, or IV Ketamine, your provider will ensure that your intranasal ketamine treatment is timed and dosed appropriately within that broader plan.
Meet with our clinical team for a thorough review of your mental health history, current symptoms, previous treatments, and medical background. We assess whether intranasal ketamine is appropriate for your situation and answer every question before we write any prescription.
Your provider walks you through exactly what to expect during administration and monitoring, how intranasal ketamine fits within your broader care, and what a personalized treatment protocol looks like for your specific situation.
Receive your supervised administration sessions in a private, comfortable clinical environment, with continuous monitoring and your care team present from the moment you arrive to the moment you leave with your arranged transportation.
Many people notice meaningful changes in mood and symptom burden within hours of their first session. We track your progress closely and adjust your protocol based on your real-time response, not a fixed schedule.
If major depression, treatment-resistant depression, or suicidal depression has not responded to conventional treatment, intranasal ketamine provides clinician-supervised access to the same glutamatergic, neuroplastic mechanism that makes ketamine one of the most significant psychiatric discoveries of the past 30 years, without IV administration.
At HOPE Therapeutics, our clinicians prescribe, supervise, and integrate intranasal ketamine with the full range of neuroplastic care we offer. Schedule your consultation to find out whether it is the right next step for you.
Dai, Y., Harrison, B. J., Davey, C. G., & Steward, T. (2025). Towards an expanded neurocognitive account of ketamine’s rapid antidepressant effects. International Journal of Neuropsychopharmacology, 28(2), pyaf010. https://doi.org/10.1093/ijnp/pyaf010
Kwan, A. C. (2020). Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines. Nature Communications, 11(1), 72. https://doi.org/10.1038/s41467-019-13809-8
Pardossi, S., Fagiolini, A., & Cuomo, A. (2024). Variations in BDNF and their role in the neurotrophic antidepressant mechanisms of ketamine and esketamine: A review. International Journal of Molecular Sciences, 25(23), 13098. https://doi.org/10.3390/ijms252313098
HOPE Therapeutics / NRx Pharmaceuticals is committed to protecting and respecting your privacy, and we’ll only use your personal information to contact you if you subscribe to our newsletter. You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and our commitment to protecting and respecting your privacy, please review our Privacy Policy. By clicking submit below, you consent to allow HOPE Therapeutics / NRx Pharmaceuticals to store and process the personal information submitted above to provide you with the content requested.
Effective Date: Jan 1st, 2026
1. Program Description: This messaging program sends appointment confirmation and reminder messages to customers who have booked an appointment with Hope Therapeutics through our website at https://hopetherapeutics.com/, or via our scheduling forms, and have explicitly opted in to receive SMS notifications. Opt-in is collected via web forms with a dedicated checkbox for SMS consent. Messages include scheduling confirmations, appointment reminders, rescheduling updates, and customer support communications.
2. Cancellation Instructions: You can cancel the SMS service at any time. Simply text “STOP” to the same number that sent you messages. Upon sending “STOP,” we will confirm your unsubscribe status via SMS. Following this confirmation, you will no longer receive SMS messages from us. To rejoin, sign up as you did initially, and we will resume sending SMS messages to you.
3. Support Information: If you experience issues with the messaging program, reply with the keyword “HELP” for more assistance, or reach out directly to team@hopetherapeutics.com or call 833-446-7386 during business hours.
4. Carrier Liability: Carriers are not liable for delayed or undelivered messages.
5. Message & Data Rates: Message and data rates may apply for messages sent to you from us and to us from you. Message frequency varies based on your service usage and appointment schedule. For questions about your text plan or data plan, contact your wireless provider.
6. Supported Carriers: Our SMS program works with all major U.S. wireless carriers, including AT&T, T-Mobile, Verizon, Sprint, and most regional carriers.
7. Age Restriction: You must be 18 years or older to participate in our SMS program.
8. Privacy Policy: For privacy-related inquiries, please refer to our Privacy Policy at https://hopetherapeutics.com/privacy-policy
We comply with all applicable laws and regulations, including the Telephone Consumer Protection Act (TCPA) and CTIA guidelines, regarding the use of SMS communications.
This website (the “Site”) is owned and operated by Hope Therapeutics (“COMPANY,” “we” or “us”). By using the Site, you agree to be bound by these Terms of Service and to use the Site in accordance with these Terms of Service, our Privacy Policy, and any additional terms and conditions that may apply to specific sections of the Site or to products and services available through the Site or from Hope Therapeutics.
Accessing the Site, in any manner, whether automated or otherwise, constitutes use of the Site and your agreement to be bound by these Terms of Service.
We reserve the right to change these Terms of Service or to impose new conditions on the use of the Site from time to time, in which case we will post the revised Terms of Service on this website. By continuing to use the Site after we post any such changes, you accept the Terms of Service, as modified.
This Site and all the materials available on the Site are the property of Hope Therapeutics and/or our affiliates or licensors and are protected by copyright, trademark, and other intellectual property laws. The Site is provided solely for your personal non-commercial use.
You may not use the Site or the materials available on the Site in a manner that constitutes an infringement of our rights or that has not been authorized by us.
Unless explicitly authorized, you may not modify, copy, reproduce, republish, upload, post, transmit, translate, sell, create derivative works, exploit, or distribute in any manner or medium any material from the Site. However, you may download and/or print one copy of individual pages for your personal, non-commercial use, provided that you keep intact all copyright and other proprietary notices.
By posting or submitting any material (including comments, blog entries, social media posts, photos, and videos) to us via the Site, internet groups, or other digital venues, you represent that you own the material or have obtained the necessary permissions. You grant us a royalty-free, perpetual, irrevocable, non-exclusive, worldwide license to use, modify, transmit, sell, exploit, create derivative works from, distribute, and publicly perform or display such material.
Throughout the Site, we may provide links and pointers to Internet sites maintained by third parties. Our linking to such third-party sites does not imply an endorsement or sponsorship of such sites or the information, products, or services offered on or through the sites.
The information, products, and services offered on or through the Site are provided “as is” and without warranties of any kind, either express or implied. To the fullest extent permissible pursuant to applicable law, we disclaim all warranties, including implied warranties of merchantability and fitness for a particular purpose.
You agree at all times to indemnify and hold harmless Hope Therapeutics, its affiliates, and their respective officers, directors, agents, and employees from any claims, causes of action, damages, liabilities, costs, and expenses arising out of or related to your breach of any obligation, warranty, or representation under these Terms of Service.
Certain sections of the Site may allow you to purchase products and services from third-party vendors. We are not responsible for the quality, accuracy, timeliness, reliability, or any other aspect of these products and services. If you make a purchase from a third party linked through the Site, the information obtained during your visit, including payment information, may be collected by both the merchant and us.
Your participation in any dealings with third-party vendors is solely between you and the third party. Hope Therapeutics shall not be responsible for any loss or damage incurred as a result of such dealings.
To access certain features of the Site, you may be required to register and create an account. You agree to provide accurate, current, and complete information during the registration process. You are responsible for maintaining the confidentiality of your login credentials and for all activities conducted under your account.
If you suspect unauthorized use of your account, notify us immediately at team@hopetherapeutics.com. We are not liable for any loss or damage arising from your failure to comply with this obligation.
We reserve the right to terminate or suspend your access to the Site, without notice, if we determine that you have violated these Terms of Service or engaged in conduct that we deem inappropriate or unlawful. Upon termination, you must cease all use of the Site and any content obtained from it.
These Terms of Service shall be governed by and construed in accordance with the laws of the state of Florida. Any dispute arising under these Terms shall be resolved exclusively through binding arbitration in that jurisdiction.
We may update these Terms of Service from time to time. The latest version will always be available on our website with the effective date.
For any questions regarding these Terms of Service, please contact us at:
Hope Therapeutics
Phone: 833-446-7386
Email: team@hopetherapeutics.com
Website: https://hopetherapeutics.com/
By using our website and services, you consent to these Terms of Service.
Effective Date: Jan 1st, 2026
IMPORTANT NOTICE REGARDING TEXT MESSAGING
DATA
Hope Therapeutics (“we,” “us,” or “our”) DOES NOT share customer opt-in information, including phone numbers and consent records, with any affiliates or third parties for marketing, promotional, or any other purposes unrelated to providing our direct services. All text messaging originator opt-in data is kept strictly confidential.
We collect the following types of information:
We use collected data for:
By opting into our SMS messaging services, you agree to receive text messages related to our services, including appointment reminders, customer support, and important updates.
No mobile information will be shared with third parties/affiliates for marketing/promotional purposes. Information sharing to subcontractors in support services, such as customer service is permitted. All other use case categories exclude text messaging originator opt-in data and consent; this information will not be shared with any third parties.
We implement strict data protection measures to safeguard your SMS opt-in information and consent records.
We do not sell, rent, or trade personal information. We may share information with:
All the above categories exclude text messaging originator opt-in data and consent; this information will not be shared with any third parties, excluding aggregators and providers of the Text Message services.
We implement and maintain reasonable security measures to protect your personal information:
Despite these measures, no method of transmission over the Internet or electronic storage is 100% secure. We strive to use commercially acceptable means to protect your personal information but cannot guarantee absolute security.
We use cookies and similar technologies to:
You may control cookies through your browser settings. Disabling cookies may limit your ability to use certain features of our website.
You have the right to:
To exercise these rights, please contact us using the information in Section 10.
Our website may contain links to third-party websites. We are not responsible for their privacy practices and encourage you to review their policies. This privacy policy applies only to information collected by Hope Therapeutics.
We may update this policy periodically. The latest version will always be available on our website with the effective date. For significant changes, we will notify you by email or through a notice on our website.
If you have questions about this Privacy Policy or how your information is handled, contact us at:
Hope Therapeutics
Phone: 833-446-7386
Email: team@hopetherapeutics.com
Website: https://hopetherapeutics.com/
By using our website and services, you consent to this Privacy Policy.